Skip to main content

Table 8 Comparative Effects of Cost-sharing Elimination and Covariates on Utilization Among Women > = 50. (Odds Ratio, Confidence Interval (CI), P-value)

From: Effectiveness of Medicare cost-sharing elimination for Cancer screening on utilization

Comparator: A Biennial Pap Smear
  Annual Mammogram Colonoscopy
  Odds Ratio 95% CI P-value Odds Ratio 95% CI P-value
Transition: 2011–2012 1.12 0.78–1.60 0.54 1.17 0.75–1.84 0.49
Post-policy: 2013 1.51 0.88–2.59 0.14 1.29 0.55–3.01 0.55
N 12,377 12,377